Gadolinium/terbium hybrid macromolecular complexes for bimodal imaging of atherothrombosis

Abstract. We developed a fluorescence imaging microscope system intended for the localization within artery slices of a gadolinium-based macromolecular biospecific magnetic resonance (MR) contrast agent used for the visualization of atherothrombosis. As the contrast agent is not initially fluorescent, we substitute some gadolinium ions for terbium ions to make them fluorescent while preserving their chemical characteristics. A long fluorescence emission time constant enables us to have a suitable signal-to-noise ratio, despite a low intensity, using pulsed illumination and time-gated imaging. Images of rat arteries show that the contrast agent is indeed localized on the specific regions of the tissues. We currently have a tool that allows us to understand and optimize the MR contrast agent.

[1]  Fabien Hyafil,et al.  Ferumoxtran-10–Enhanced MRI of the Hypercholesterolemic Rabbit Aorta: Relationship Between Signal Loss and Macrophage Infiltration , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[2]  J. Fujimoto.  Optical coherence tomography for ultrahigh resolution in vivo imaging , 2003, Nature Biotechnology.

[3]  V. Gulani,et al.  Magnetic resonance microscopy of morphological alterations in mouse trabecular bone structure under conditions of simulated microgravity , 2001, Magnetic resonance in medicine.

[4]  A. Zvyagin.  Multiphoton endoscopy , 2007 .

[5]  C. Corot,et al.  Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer. , 1997, Acta radiologica. Supplementum.

[6]  J E Hearst,et al.  Luminescence energy transfer using a terbium chelate: improvements on fluorescence energy transfer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Blondin,et al.  Polysaccharides for vascular cell targeting. , 2000, Critical reviews in therapeutic drug carrier systems.

[8]  Hisao Ikeda,et al.  Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates. , 2002, Journal of the American College of Cardiology.

[9]  S. Emelianov,et al.  Intravascular photoacoustic imaging using an IVUS imaging catheter , 2007, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[10]  A. Orekhov,et al.  Contribution of neovascularization and intraplaque haemorrhage to atherosclerotic plaque progression and instability , 2015, Acta physiologica.

[11]  S. Hussain,et al.  Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging , 2001, European Radiology.

[12]  René M. Botnar,et al.  In Vivo Magnetic Resonance Imaging of Coronary Thrombosis Using a Fibrin-Binding Molecular Magnetic Resonance Contrast Agent , 2004, Circulation.

[13]  Emmanuelle Canet-Soulas,et al.  A new macromolecular paramagnetic MR contrast agent binds to activated human platelets. , 2007, Contrast media & molecular imaging.

[14]  Zahi A Fayad,et al.  Tyrosine polyethylene glycol (PEG)‐micelle magnetic resonance contrast agent for the detection of lipid rich areas in atherosclerotic plaque , 2009, Magnetic resonance in medicine.

[15]  J. Michel,et al.  Elastase-induced experimental aneurysms in rats. , 1990, Circulation.

[16]  R. Weissleder,et al.  Optical-based molecular imaging: contrast agents and potential medical applications , 2003, European Radiology.

[17]  J. Bünzli.  Lanthanide luminescence for biomedical analyses and imaging. , 2010, Chemical reviews.

[18]  I. Solomon.  Relaxation Processes in a System of Two Spins , 1955 .

[19]  L. Jennings.  Role of platelets in atherothrombosis. , 2009, The American journal of cardiology.

[20]  R. Lauffer,et al.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.

[21]  A. Varki,et al.  Selectin inhibition: synthesis and evaluation of novel sialylated, sulfated and fucosylated oligosaccharides, including the major capping group of GlyCAM-1. , 1997, Glycobiology.

[22]  André Briguet,et al.  Biomimetic MRI Contrast Agent for Imaging of Inflammation in Atherosclerotic Plaque of ApoE−/− Mice: A Pilot Study , 2009, Investigative radiology.

[23]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. , 1990, Radiology.

[24]  Yan Xing,et al.  Radiolabeled Nanoparticles for Multimodality Tumor Imaging , 2014, Theranostics.

[25]  E.,et al.  Paramagnetic Metal Complexes as Water Proton Relaxation Agents for NMR Imaging : Theory and Design , 2001 .

[26]  S. Gambhir,et al.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.

[27]  Mark J Post,et al.  Nanoparticles for optical molecular imaging of atherosclerosis. , 2009, Small.

[28]  T. Lövgren,et al.  Europium as a label in time-resolved immunofluorometric assays. , 1984, Analytical biochemistry.

[29]  R E Poelmann,et al.  Magnetic resonance microscopy at 17.6‐Tesla on chicken embryos in vitro , 2001, Journal of magnetic resonance imaging : JMRI.

[30]  B. Rutt,et al.  Application of the static dephasing regime theory to superparamagnetic iron‐oxide loaded cells , 2002, Magnetic resonance in medicine.

[31]  Ralph Weissleder,et al.  Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents. , 2002, Academic radiology.

[32]  Jean-Baptiste Michel,et al.  Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans , 2010, Cardiovascular research.

[33]  Emmanuelle Canet-Soulas,et al.  Synthesis and evaluation of a tri-tyrosine decorated dextran MR contrast agent for vulnerable plaque detection. , 2011, Chemical communications.

[34]  Ilkka Hemmilä,et al.  Time-resolved fluorometry: an overview of the labels and core technologies for drug screening applications , 1997 .

[35]  Chun Yuan,et al.  Presence of Intraplaque Hemorrhage Stimulates Progression of Carotid Atherosclerotic Plaques: A High-Resolution Magnetic Resonance Imaging Study , 2005, Circulation.

[36]  Otto W. Witte,et al.  Possibilities and limitations for high resolution small animal MRI on a clinical whole-body 3T scanner , 2011, Magnetic Resonance Materials in Physics, Biology and Medicine.

[37]  Maurice W. Windsor,et al.  Luminescence and Energy Transfer in Solutions of Rare‐Earth Complexes. I. Enhancement of Fluorescence by Deuterium Substitution , 1965 .

[38]  K. Hanaoka,et al.  Development of responsive lanthanide-based magnetic resonance imaging and luminescent probes for biological applications. , 2010, Chemical & pharmaceutical bulletin.

[39]  J. Gillard,et al.  Advances in MRI for the evaluation of carotid atherosclerosis. , 2015, The British journal of radiology.

[40]  Jerzy Konarski,et al.  Quantum efficiency of the luminescence of Eu(III), Tb(III) and Dy(III) in aqueous solutions , 1989 .

[41]  D Revel,et al.  Kinetic characterization of CMD‐A2‐Gd‐DOTA as an intravascular contrast agent for myocardial perfusion measurement with MRI , 2000, Magnetic resonance in medicine.

[42]  A Todd-Pokropek,et al.  Analysis of the distribution of MRI contrast agents in the livers of small animals by means of complementary microscopies , 2003, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[43]  T. Springer,et al.  Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. , 1995, Annual review of physiology.

[44]  Ralph Weissleder,et al.  Long-circulating iron oxides for MR imaging , 1995 .

[45]  Jean-Baptiste Michel,et al.  Intraplaque haemorrhages as the trigger of plaque vulnerability , 2011, European heart journal.

[46]  Jean-Claude G. Bünzli,et al.  Lanthanide Luminescent Bioprobes (LLBs) , 2009 .

[47]  R. Lauffer,et al.  Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design , 1987 .

[48]  P. Selvin,et al.  Quantum yields of luminescent lanthanide chelates and far-red dyes measured by resonance energy transfer. , 2001, Journal of the American Chemical Society.

[49]  Stefan Ropele,et al.  Super‐resolution MRI using microscopic spatial modulation of magnetization , 2010, Magnetic resonance in medicine.

[50]  Nicolaas Bloembergen,et al.  Proton Relaxation Times in Paramagnetic Solutions. Effects of Electron Spin Relaxation , 1961 .

[51]  Jean-Baptiste Michel,et al.  Ultrasmall superparamagnetic iron oxide nanoparticles coated with fucoidan for molecular MRI of intraluminal thrombus. , 2015, Nanomedicine.

[52]  Atle Bjørnerud,et al.  The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system , 2004, NMR in biomedicine.

[53]  Jean-Baptiste Michel,et al.  MR imaging of iron phagocytosis in intraluminal thrombi of abdominal aortic aneurysms in humans. , 2010, Radiology.

[54]  Guilan Wang,et al.  Lanthanide Complex-Based Fluorescence Label for Time-Resolved Fluorescence Bioassay , 2005, Journal of Fluorescence.

[55]  B Hamm,et al.  New generation of monomer‐stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: Preclinical results in rats and rabbits , 2000, Journal of magnetic resonance imaging : JMRI.

[56]  Peter Seizer,et al.  Platelets in Inflammation and Atherogenesis , 2015, Front. Immunol..

[57]  D. Vestweber,et al.  Mechanisms that regulate the function of the selectins and their ligands. , 1999, Physiological reviews.

[58]  D. Francis,et al.  Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations , 2013, International journal of cardiology.

[59]  Gschneid.  Handbook on the Physics and Chemistry of Rare Earths , 1988 .

[60]  Thorfinnur Gunnlaugsson,et al.  Photochemistry and Photophysics of Coordination Compounds: Lanthanides , 2007 .

[61]  Nicolaas Bloembergen,et al.  Proton Relaxation Times in Paramagnetic Solutions , 1957 .

[62]  M. Roth.  Fluorescence reaction for amino acids. , 1971, Analytical chemistry.

[63]  Klaas Nicolay,et al.  MRI contrast agents: current status and future perspectives. , 2007, Anti-cancer agents in medicinal chemistry.

[64]  Thierry Gacoin,et al.  Multifunctional rare-Earth vanadate nanoparticles: luminescent labels, oxidant sensors, and MRI contrast agents. , 2014, ACS nano.

[65]  W. L. Scaff,et al.  Fluorescent Europium Chelate Stain , 1969 .

[66]  Junhua Yu,et al.  Engineering emissive europium and terbium complexes for molecular imaging and sensing. , 2006, Dalton transactions.

[67]  Damini Dey,et al.  Imaging of coronary atherosclerosis — evolution towards new treatment strategies , 2016, Nature Reviews Cardiology.

[68]  Phalla Ou,et al.  Strong and specific interaction of ultra small superparamagnetic iron oxide nanoparticles and human activated platelets mediated by fucoidan coating , 2014 .

[69]  Rodger P McEver,et al.  Selectin-carbohydrate interactions during inflammation and metastasis , 1997, Glycoconjugate Journal.

[70]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[71]  Chun Yuan,et al.  Quantitative Magnetic Resonance Imaging Analysis of Neovasculature Volume in Carotid Atherosclerotic Plaque , 2003, Circulation.

[72]  Jean-Baptiste Michel,et al.  Thrombus versus Wall Biological Activities in Experimental Aortic Aneurysms , 2009, Journal of Vascular Research.

[73]  G. A. Crosby,et al.  THE EFFECT OF DEUTERIUM ON THE LUMINESCENCE DECAY TIMES OF SOLVATED RARE EARTH CHLORIDES , 1964 .

[74]  R P McEver,et al.  Adhesive Interactions of Leukocytes, Platelets, and the Vessel Wall during Hemostasis and Inflammation , 2001, Thrombosis and Haemostasis.

[75]  D. Wagner,et al.  New links between inflammation and thrombosis. , 2005, Arteriosclerosis, thrombosis, and vascular biology.